Aurinia Pharmaceuticals (AUPH) has released an update.Don't Miss our Black Friday Offers:Discover the latest stocks recommended by top Wall ...

New Guidelines Presented at ACR Convergence 2024 Recommend First-Line Therapy with LUPKYNIS ® (voclosporin) as Part of a Triple Immunosuppressive LN Treatment Regimen. ROCKVILLE, ...

GSA Capital Partners LLP cut its position in shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) by 44.9% during the third quarter, according to the company in its most recent ...

Aurinia Pharmaceuticals (AUPH) has released an update. Aurinia Pharmaceuticals has unveiled new data underscoring the importance of early ...

Jeffrey Allen Bailey, a director at Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH), recently reported a sale of company stock. According to a filing with the Securities and Exchange Commission ...

Aurinia management will host one-on-one meetings with investors and will participate in a fireside chat and Q&A session on Wednesday, November 20, at 12:00 PM GMT/7:00 AM EST. This session will not ...

Karen L. Smith, a director at Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH), recently sold a portion of her holdings in the company. According to a Form 4 filing with the Securities and Exchange ...

ROCKVILLE, Md. & EDMONTON, Alberta--(BUSINESS WIRE)-- Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that the Company’s management team will attend the ...

Aurinia Pharmaceuticals Reports Q3 and Nine Months 2024 Financial and Operational Results, Announces Strategic Restructuring to Sharpen Focus on Continued LUPKYNIS® Growth and AUR200 Development ...

His previous board experience includes Aurinia Pharmaceuticals, Exicure (chairman), Assertio (chairman), Raptor Pharmaceutical Corp., XOMA Corporation, and Sucampo Pharmaceuticals. Mr. Walbert is also ...